Table 1 Characteristics of enrolled patients (N = 702).

From: Prevalence of hepatitis D virus infection among patients with chronic hepatitis B infection in a tertiary care centre in Thailand

Characteristics

Number (%)/mean ± SD

Male sex

418 (59.5%)

Age (in years)

54.01 ± 12.01

Virological characteristics

 HBeAg

Positive 89 (12.7%)

Negative 452 (64.3%)

Missing data 161 (22.9%)

 Anti-HCV

Positive 4 (0.6%)

Negative 637 (90.7%)

Missing data 61 (8.7%)

 Anti-HIV

Positive 1 (0.1%)

Negative 635 (90.5%)

Missing data 66 (9.4%)

Clinical characteristics

 HBV carriers

209 (29.8%)

 Under HBV antiviral treatment

471 (67.1%)

 Regimen, N = 471

 

  Lamivudine (LAM)

29 (6.2%)

  Entecavir (ETV)

172 (36.5%)

  Tenofovir (TDF & TAF)

258 (54.8%)

  Combined ETV and TDF/TAF

11 (2.3%)

 Interferon

1 (0.2%)

 Cirrhosis (with and without HCC)

197 (28.1%)

 CTP, N = 197

 

  A

166 (84.3%)

  B

22 (11.2%)

  C

9 (4.6%)

 Hepatocellular carcinoma (HCC)

152 (21.7%)

  Active

80 (11.4%)

 BCLC

  A

23 (28.7%)

  B

17 (21.3%)

  C

40 (50.0%)

 Ascites

24 (3.4%)

 Variceal bleeding

22 (3.1%)

  1. Anti-HCV Hepatitis C antibody, anti-HIV Human immunodeficiency virus antibody, BCLC Barcelona Clinic Liver Cancer, CTP Child–Turcotte–Pugh, HBeAg Hepatitis B e-antigen, SD standard deviation.
Back to article page